Financials
Income statement
Fiscal date | Mar 2025 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | — | 1.0B | 980.2M |
Cost of revenue | — | — | 1.0B | 935.6M |
Gross profit | — | — | 1.4M | 44.6M |
Operating expense | ||||
Research & development | — | — | 55.9M | 51.5M |
Selling general and admin | — | — | -244.0M | 278.2M |
Other operating expenses | — | — | 7.2M | 10.9M |
Operating income | — | — | -197.7M | -146.3M |
Non operating interest income | ||||
Income | — | — | 27.4M | -19.5M |
Expense | — | — | 55.3M | 42.0M |
Other income expense | — | — | — | — |
Pretax income | — | — | -439.4M | -190.7M |
Tax provision | — | — | 3.8M | 1.5M |
Net income | — | — | -443.2M | -192.2M |
Basic EPS | -0.1 | -0.1 | — | — |
Diluted EPS | -0.1 | -0.1 | — | — |
Basic average shares | 1.0B | 1.0B | — | — |
Diluted average shares | 1.0B | 1.0B | — | — |
EBITDA | — | — | -333.4M | -143.9M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | 49.7M | 34.2M |
Preferred stock dividends | — | — | 0 | 0 |